- Breast biopsy devices are essential tools used to diagnose breast cancer by removing tissue samples from suspicious areas of the breast for further examination. These devices include needle-based and vacuum-assisted biopsy systems
- The demand for breast biopsy devices is primarily driven by the rising incidence of breast cancer, increased awareness of early detection, and the growing preference for minimally invasive procedures
- North America is expected to dominate the breast biopsy devices market with a market share of 43.6%, due to advanced healthcare infrastructure, high adoption of cutting-edge biopsy technologies, and strong presence of key market players
- Asia-Pacific is expected to be the fastest growing region in the breast biopsy devices market, during the forecast period due to rapid expansion of healthcare infrastructure, increasing awareness about breast cancer, and rising demand for early diagnostic procedures
- Needle-based biopsy guns segment is expected to dominate the market with a market share of 43.6% due to its minimally invasive nature, faster procedure times, and high accuracy in tissue sampling. In addition, their widespread adoption in both hospital and outpatient settings for diagnosing breast abnormalities further boosts segment growth
